Evernorth is entering into a partnership with CarepathRx Health System Solutions to help hospitals, health systems and their physicians diversify their offerings, while enabling stronger patient connections to needed specialty care for chronic and complex conditions.
The partnership between CarepathRx Health System Solutions and Evernorth brings together diverse specialty and care expertise to improve, expand, and accelerate pharmacy care delivery for the growing number of patients with chronic and complex care needs.
A robust education and treatment plan are key to helping those who suffer from one of the most common pregnancy complications.
The EncircleRxSM portfolio is part of our GLP-1 Management Suite of Solutions that helps plan sponsors reduce costs and enhance outcomes. EncircleRx: Cardiodiabesity gives clients optionality and predictability in managing cardiodiabesity—obesity, diabetes and cardiovascular disease—with the first-ever GLP-1 financial guarantee from a PBM.
Obesity, diabetes, and cardiovascular disease are on the rise. Left unmanaged, these comorbid conditions can cause medical expenses to skyrocket and lead to poor health outcomes, inclusive of disability, and death.
Our study, which is based on 495,180 adults with diagnosed ADHD, uncovered that social and economic factors impact the prevalence of ADHD treatment.
Dr. Eric Weil, chief medical officer of MDLIVE by Evernorth, has been able to blend his dream of being a doctor with his passion for health care innovation, helping to bring quality health care to millions of Americans in the comfort of their own homes.
We believe robust pharmacy networks are critical to ensuring access for Medicare customers and that individual pharmacists deserve the opportunity to make the decision that’s best for their business.